Results 1 to 10 of about 147,042 (308)

Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers

Circulation, 2002
Matthijs Boekholdt, Jcm Meijers
exaly  

Urgent Need to Measure Effects of Direct Oral Anticoagulants

Circulation, 2016
Jeffrey I. Weitz, John W. Eikelboom
exaly  

Introduction: Are Natural Anticoagulants Candidates for Modulating the Inflammatory Response to Endotoxin?

Blood, 2000
C T Esmon, Charles T Esmon
exaly  

Laboratory Assessment of the Anticoagulant Effects of the Next Generation of Oral Anticoagulants

Journal of Thrombosis and Haemostasis, 2013
Jeffrey I. Weitz, Eduardo Ramacciotti
exaly  

A Double-Blind Trial to Assess Long-Term Oral Anticoagulant Therapy in Elderly Patients After Myocardial Infarction

Lancet, The, 1980
exaly  

Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism

Annals of Internal Medicine, 2003
James Douketis, Peter T Choi
exaly  

Update of the Guidelines for Lupus Anticoagulant Detection

Journal of Thrombosis and Haemostasis, 2009
Vittorio Pengo, G Reber, J H Rand
exaly  

Pharmacology of Anticoagulants Used in the Treatment of Venous Thromboembolism

Journal of Thrombosis and Thrombolysis, 2016
John Fanikos, Allison E Burnett
exaly  

Efficacy of Oral Anticoagulants Compared With Aspirin After Infrainguinal Bypass Surgery (the Dutch Bypass Oral Anticoagulants or Aspirin Study): A Randomised Trial

Lancet, The, 2000
exaly  

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

Research and Practice in Thrombosis and Haemostasis, 2022
Background Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded)
Emmanuel J. Favaloro, Leonardo Pasalic
doaj   +3 more sources